Algorhythm Reports 1,367% Revenue Surge and 49% Liability Reduction

RIMERIME

Revenue surged 1,367% to $4.4 million in 2025 as operating expenses fell 19.5%, cutting net loss by 32% to $16.6 million. Total liabilities declined 49.3% to $14.6 million, cash rose to $6.1 million year-end, and SemiCab achieved an annualized $10 million ARR.

1. 2025 Financial Results

Algorhythm Holdings posted revenue of $4.4 million in 2025, up 1,367% from $0.3 million a year earlier, while operating expenses fell 19.5% to $6.6 million and net loss narrowed 32% to $16.6 million, driven in part by reduced non-cash warrant charges. Total liabilities dropped 49.3% to $14.6 million and cash on hand was $6.1 million as of December 31, 2025.

2. SemiCab Business Growth

SemiCab generated all of the year's revenue in just eight months post-acquisition, achieving a $10 million annualized run rate by year-end. During 2025, SemiCab secured five new contracts with major FMCG firms in India and six expansions worth between 100% and 600% increases, including a $6 million deal with Asian Paints.

3. 2026 Outlook

Management reports cash increased to $10.9 million by March 25, 2026, strengthening the balance sheet for planned expansion. The launch of the Apex SaaS platform targets the $450 billion U.S. full-truckload market with asset-light licensing and a strategy to drive high-margin recurring revenue.

4. Peer Comparison

An analysis comparing Algorhythm to Nexalin Technology highlights differences in institutional ownership, dividend policies, analyst ratings, valuation metrics, risk profiles, and profitability, providing investors with a side-by-side evaluation of two small-cap business services stocks.

Sources

FD